Literature DB >> 17112924

Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation.

F Chen1, T Bando, T Fukuse, M Omasa, A Aoyama, H Hamakawa, T Fujinaga, T Shoji, H Sakai, N Hanaoka, H Wada.   

Abstract

Living-donor lobar lung transplantation (LDLLT) has been applied to patients with various end-stage lung diseases. The recurrence of pulmonary lymphangioleiomyomatosis (LAM) after lung transplantation has been rarely reported. Herein, we report a case of recurrent pulmonary LAM after LDLLT. A 24-year-old woman presented with pneumothorax and infiltrates in the left lung 1 year after bilateral LDLLT for LAM. These symptoms and radiologic findings occurred repeatedly and then improved quickly. Thereafter, computed tomography of the chest revealed a tiny emphysematous change of the subpleural region in the left lung, which was exacerbated gradually and was finally diagnosed as LAM recurrence by transbronchial lung biopsy. In previous reports of LAM recurrence, the diagnosis was made at the time of autopsy. This is also the first reported case diagnosed early, that is, when the patient was alive and her allograft had not deteriorated badly.

Entities:  

Mesh:

Year:  2006        PMID: 17112924     DOI: 10.1016/j.transproceed.2006.08.145

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation.

Authors:  Khawaja S Zaki; Zahra Aryan; Atul C Mehta; Olufemi Akindipe; Marie Budev
Journal:  World J Transplant       Date:  2016-03-24

Review 2.  Recurrence of primary disease following lung transplantation.

Authors:  Dorina Rama Esendagli; Prince Ntiamoah; Elif Kupeli; Abhishek Bhardwaj; Subha Ghosh; Sanjay Mukhopadhyay; Atul C Mehta
Journal:  ERJ Open Res       Date:  2022-05-30

3.  Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis.

Authors:  Riffat Meraj; Kathryn A Wikenheiser-Brokamp; Lisa R Young; Sue Byrnes; Francis X McCormack
Journal:  Front Med       Date:  2012-12-07       Impact factor: 4.592

4.  Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

Authors:  Nishant Gupta; Geraldine A Finlay; Robert M Kotloff; Charlie Strange; Kevin C Wilson; Lisa R Young; Angelo M Taveira-DaSilva; Simon R Johnson; Vincent Cottin; Steven A Sahn; Jay H Ryu; Kuniaki Seyama; Yoshikazu Inoue; Gregory P Downey; MeiLan K Han; Thomas V Colby; Kathryn A Wikenheiser-Brokamp; Cristopher A Meyer; Karen Smith; Joel Moss; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

5.  Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase.

Authors:  Ho Yin Ng; Brian Gregory George Oliver; Janette Kay Burgess; Vera P Krymskaya; Judith Lee Black; Lyn M Moir
Journal:  J Cell Mol Med       Date:  2015-08-18       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.